Deferiprone Has a Dose-Dependent Effect on Liver Iron Concentration

Liver iron concentration, stainable iron, and total body storage iron.

Liver iron concentration has been determined chemically in 154 liver biopsies and the findings compared with the routine histological assessment of stainable parenchymal iron, performed by an independent observer. There was a significant correlation between liver iron concentration and histochemical grading but the relationship did not have a normal linear form. Absence of stainable iron corres...

Umbelliprenin, a bioactive constituent from the genus Ferula has cytotoxic and apoptotic activity in a dose- and time-dependent manner

Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients

The 1-year THALASSA study enrolled 166 patients with various non-transfusion-dependent thalassemia (NTDT) syndromes, degrees of iron burden and patient characteristics, and demonstrated the overall efficacy and safety of deferasirox in reducing liver iron concentration (LIC) in these patients. Here, reduction in LIC with deferasirox 5 and 10 mg/kg/day starting dose groups is shown to be consist...

The effect of increasing of iron concentration on the physical properties of zinc-iron ferrite nanoparticles

In this research, zinc-iron ferrite nanoparticles were synthesized by thermal treatment method. The presence of crystalline phases by X-ray diffraction (XRD) was determined by X-ray diffraction (XRD), which confirmed the presence of crystalline phases in all nanoparticles. The particle size and morphology of the nanoparticles were obtained using Field Emission Scanning Electron Microscopy (FESE...

Effect of Iron-Chelator Deferiprone on the In Vitro Growth of Staphylococci

The standard iron-chelator deferoxamine is known to prevent the growth of coagulase-negative staphylococci (CoNS) which are major pathogens in iron-overloaded patients. However, we found that deferoxamine rather promotes the growth of coagulase-positive Staphylococcus aureus. Accordingly, we tested whether deferiprone, a new clinically-available iron-chelator, can prevent the growth of S. aureu...